Protocol Design Featured Articles
-
Unsure About The New ICH Guidelines? TransCelerate Debuts 13 Tools To Help
4/23/2025
TransCelerate BioPharma's Tashan Mistree discusses 13 new tools created alongside the Association of Clinical Research Organizations (ACRO) to support ICH GCP E6(R3) adoption.
-
"A Long Way To Go": Patient Wants Better Listening From Pharma
4/15/2025
Aspirin exacerbated respiratory disease (AERD) patient advocate Rhonda Nelson shares her patient experience and explains how she thinks pharma companies can better integrate the patient voice into clinical trial design.
-
Smart Trial Design In Cell Therapy: Fast-Tracking Without Compromising
4/10/2025
Discover clinical trial designs and real-life examples that enable fast and safe studies in cell therapy.
-
The Evolution Of A Clinical Research Coordinator
4/9/2025
Briana White is a CRC with Superior Clinical Research, a small clinical research site in Smithfield NC. She talks about how she got into the clinical industry and what she struggles with in her job (spoiler alert: it involves tech).
-
FAQ On The Clinical Trial Process
4/4/2025
What are clinical trials and how do they typically unfold? In this Q&A, you will learn about the four distinct clinical trial phases, participation eligibility, recruitment and more.
-
The Early Phase Australian Advantage For Biotech Companies
4/4/2025
Australia's clinical landscape presents a compelling environment for early-phase clinical trials, characterized by regulatory efficiency and cost-effectiveness.
-
Feasibility/Site Selection Process Ripe For Improvement
4/1/2025
One key to a more effective feasibility process is more transparent communications and collaboration between sponsors, CROs, and sites. Sponsors must provide clear information to each site to enable a more accurate recruitment assessment, and sites must properly digest the information to give an accurate projection. But how?
-
If Patients Want A Better Quality Of Life, Why Isn't That A Focus For Pharma?
3/25/2025
Medical oncologist Frédéric Fiteni, Ph.D. reveals the widespread industry reluctance to study patient quality of life, describes its importance to patient satisfaction, and offers best practices for its integration.
-
Gilead Sees Success With HIV PrEP Trial In South Africa
3/24/2025
Gilead Sciences' Moupali Das, MD, MPH shares how her team completed the Phase 3 trial for HIV PrEP in South Africa amid challenging conditions.
-
FAQs On The siRNA Therapeutics
3/21/2025
Stay ahead in the rapidly evolving field of siRNA therapeutics by exploring the latest clinical trends, breakthrough delivery technologies, combination strategies, and global regulatory pathways.